Global Gastroparesis Drugs Market Growth 2025-2031

January 2025 | 95 pages | ID: G4DEE25526E4EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Gastroparesis Drugs market size is predicted to grow from US$ 6018 million in 2025 to US$ 7820 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031.

Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.

North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.

Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.

LP Information, Inc. (LPI) ' newest research report, the “Gastroparesis Drugs Industry Forecast” looks at past sales and reviews total world Gastroparesis Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Gastroparesis Drugs sales for 2025 through 2031. With Gastroparesis Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastroparesis Drugs industry.

This Insight Report provides a comprehensive analysis of the global Gastroparesis Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastroparesis Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastroparesis Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastroparesis Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastroparesis Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastroparesis Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Prokinetic Agents
• Antiemetic Agents
• Others

Segmentation by Application:

• Diabetic Gastroparesis
• Idiopathic Gastroparesis

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Sumitomo
• Cadila Pharmaceuticals
• Sanofi
• Teva
• Johnson & Johnson
• Pfizer
• Kyowa Kirin Pharmaceuticals
• Hanmi Pharm
• Ani Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Gastroparesis Drugs market?

What factors are driving Gastroparesis Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Gastroparesis Drugs market opportunities vary by end market size?

How does Gastroparesis Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Gastroparesis Drugs Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Gastroparesis Drugs by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Gastroparesis Drugs by Country/Region, 2020, 2024 & 2031
2.2 Gastroparesis Drugs Segment by Type
  2.2.1 Prokinetic Agents
  2.2.2 Antiemetic Agents
  2.2.3 Others
2.3 Gastroparesis Drugs Sales by Type
  2.3.1 Global Gastroparesis Drugs Sales Market Share by Type (2020-2025)
  2.3.2 Global Gastroparesis Drugs Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Gastroparesis Drugs Sale Price by Type (2020-2025)
2.4 Gastroparesis Drugs Segment by Application
  2.4.1 Diabetic Gastroparesis
  2.4.2 Idiopathic Gastroparesis
2.5 Gastroparesis Drugs Sales by Application
  2.5.1 Global Gastroparesis Drugs Sale Market Share by Application (2020-2025)
  2.5.2 Global Gastroparesis Drugs Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Gastroparesis Drugs Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Gastroparesis Drugs Breakdown Data by Company
  3.1.1 Global Gastroparesis Drugs Annual Sales by Company (2020-2025)
  3.1.2 Global Gastroparesis Drugs Sales Market Share by Company (2020-2025)
3.2 Global Gastroparesis Drugs Annual Revenue by Company (2020-2025)
  3.2.1 Global Gastroparesis Drugs Revenue by Company (2020-2025)
  3.2.2 Global Gastroparesis Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Gastroparesis Drugs Sale Price by Company
3.4 Key Manufacturers Gastroparesis Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Gastroparesis Drugs Product Location Distribution
  3.4.2 Players Gastroparesis Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR GASTROPARESIS DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Gastroparesis Drugs Market Size by Geographic Region (2020-2025)
  4.1.1 Global Gastroparesis Drugs Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Gastroparesis Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Gastroparesis Drugs Market Size by Country/Region (2020-2025)
  4.2.1 Global Gastroparesis Drugs Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Gastroparesis Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gastroparesis Drugs Sales Growth
4.4 APAC Gastroparesis Drugs Sales Growth
4.5 Europe Gastroparesis Drugs Sales Growth
4.6 Middle East & Africa Gastroparesis Drugs Sales Growth

5 AMERICAS

5.1 Americas Gastroparesis Drugs Sales by Country
  5.1.1 Americas Gastroparesis Drugs Sales by Country (2020-2025)
  5.1.2 Americas Gastroparesis Drugs Revenue by Country (2020-2025)
5.2 Americas Gastroparesis Drugs Sales by Type (2020-2025)
5.3 Americas Gastroparesis Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Gastroparesis Drugs Sales by Region
  6.1.1 APAC Gastroparesis Drugs Sales by Region (2020-2025)
  6.1.2 APAC Gastroparesis Drugs Revenue by Region (2020-2025)
6.2 APAC Gastroparesis Drugs Sales by Type (2020-2025)
6.3 APAC Gastroparesis Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Gastroparesis Drugs by Country
  7.1.1 Europe Gastroparesis Drugs Sales by Country (2020-2025)
  7.1.2 Europe Gastroparesis Drugs Revenue by Country (2020-2025)
7.2 Europe Gastroparesis Drugs Sales by Type (2020-2025)
7.3 Europe Gastroparesis Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Gastroparesis Drugs by Country
  8.1.1 Middle East & Africa Gastroparesis Drugs Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Gastroparesis Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Gastroparesis Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Gastroparesis Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gastroparesis Drugs
10.3 Manufacturing Process Analysis of Gastroparesis Drugs
10.4 Industry Chain Structure of Gastroparesis Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Gastroparesis Drugs Distributors
11.3 Gastroparesis Drugs Customer

12 WORLD FORECAST REVIEW FOR GASTROPARESIS DRUGS BY GEOGRAPHIC REGION

12.1 Global Gastroparesis Drugs Market Size Forecast by Region
  12.1.1 Global Gastroparesis Drugs Forecast by Region (2026-2031)
  12.1.2 Global Gastroparesis Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Gastroparesis Drugs Forecast by Type (2026-2031)
12.7 Global Gastroparesis Drugs Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Sumitomo
  13.1.1 Sumitomo Company Information
  13.1.2 Sumitomo Gastroparesis Drugs Product Portfolios and Specifications
  13.1.3 Sumitomo Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Sumitomo Main Business Overview
  13.1.5 Sumitomo Latest Developments
13.2 Cadila Pharmaceuticals
  13.2.1 Cadila Pharmaceuticals Company Information
  13.2.2 Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
  13.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Cadila Pharmaceuticals Main Business Overview
  13.2.5 Cadila Pharmaceuticals Latest Developments
13.3 Sanofi
  13.3.1 Sanofi Company Information
  13.3.2 Sanofi Gastroparesis Drugs Product Portfolios and Specifications
  13.3.3 Sanofi Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Sanofi Main Business Overview
  13.3.5 Sanofi Latest Developments
13.4 Teva
  13.4.1 Teva Company Information
  13.4.2 Teva Gastroparesis Drugs Product Portfolios and Specifications
  13.4.3 Teva Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Teva Main Business Overview
  13.4.5 Teva Latest Developments
13.5 Johnson & Johnson
  13.5.1 Johnson & Johnson Company Information
  13.5.2 Johnson & Johnson Gastroparesis Drugs Product Portfolios and Specifications
  13.5.3 Johnson & Johnson Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Johnson & Johnson Main Business Overview
  13.5.5 Johnson & Johnson Latest Developments
13.6 Pfizer
  13.6.1 Pfizer Company Information
  13.6.2 Pfizer Gastroparesis Drugs Product Portfolios and Specifications
  13.6.3 Pfizer Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Pfizer Main Business Overview
  13.6.5 Pfizer Latest Developments
13.7 Kyowa Kirin Pharmaceuticals
  13.7.1 Kyowa Kirin Pharmaceuticals Company Information
  13.7.2 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
  13.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Kyowa Kirin Pharmaceuticals Main Business Overview
  13.7.5 Kyowa Kirin Pharmaceuticals Latest Developments
13.8 Hanmi Pharm
  13.8.1 Hanmi Pharm Company Information
  13.8.2 Hanmi Pharm Gastroparesis Drugs Product Portfolios and Specifications
  13.8.3 Hanmi Pharm Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Hanmi Pharm Main Business Overview
  13.8.5 Hanmi Pharm Latest Developments
13.9 Ani Pharmaceuticals
  13.9.1 Ani Pharmaceuticals Company Information
  13.9.2 Ani Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
  13.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Ani Pharmaceuticals Main Business Overview
  13.9.5 Ani Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Gastroparesis Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Gastroparesis Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Prokinetic Agents
Table 4. Major Players of Antiemetic Agents
Table 5. Major Players of Others
Table 6. Global Gastroparesis Drugs Sales byType (2020-2025) & (Kg)
Table 7. Global Gastroparesis Drugs Sales Market Share byType (2020-2025)
Table 8. Global Gastroparesis Drugs Revenue byType (2020-2025) & ($ million)
Table 9. Global Gastroparesis Drugs Revenue Market Share byType (2020-2025)
Table 10. Global Gastroparesis Drugs Sale Price byType (2020-2025) & (US$/mg)
Table 11. Global Gastroparesis Drugs Sale by Application (2020-2025) & (Kg)
Table 12. Global Gastroparesis Drugs Sale Market Share by Application (2020-2025)
Table 13. Global Gastroparesis Drugs Revenue by Application (2020-2025) & ($ million)
Table 14. Global Gastroparesis Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Gastroparesis Drugs Sale Price by Application (2020-2025) & (US$/mg)
Table 16. Global Gastroparesis Drugs Sales by Company (2020-2025) & (Kg)
Table 17. Global Gastroparesis Drugs Sales Market Share by Company (2020-2025)
Table 18. Global Gastroparesis Drugs Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Gastroparesis Drugs Revenue Market Share by Company (2020-2025)
Table 20. Global Gastroparesis Drugs Sale Price by Company (2020-2025) & (US$/mg)
Table 21. Key Manufacturers Gastroparesis Drugs Producing Area Distribution and Sales Area
Table 22. Players Gastroparesis Drugs Products Offered
Table 23. Gastroparesis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Gastroparesis Drugs Sales by Geographic Region (2020-2025) & (Kg)
Table 27. Global Gastroparesis Drugs Sales Market Share Geographic Region (2020-2025)
Table 28. Global Gastroparesis Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Gastroparesis Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Gastroparesis Drugs Sales by Country/Region (2020-2025) & (Kg)
Table 31. Global Gastroparesis Drugs Sales Market Share by Country/Region (2020-2025)
Table 32. Global Gastroparesis Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Gastroparesis Drugs Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
Table 35. Americas Gastroparesis Drugs Sales Market Share by Country (2020-2025)
Table 36. Americas Gastroparesis Drugs Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Gastroparesis Drugs Sales byType (2020-2025) & (Kg)
Table 38. Americas Gastroparesis Drugs Sales by Application (2020-2025) & (Kg)
Table 39. APAC Gastroparesis Drugs Sales by Region (2020-2025) & (Kg)
Table 40. APAC Gastroparesis Drugs Sales Market Share by Region (2020-2025)
Table 41. APAC Gastroparesis Drugs Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Gastroparesis Drugs Sales byType (2020-2025) & (Kg)
Table 43. APAC Gastroparesis Drugs Sales by Application (2020-2025) & (Kg)
Table 44. Europe Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
Table 45. Europe Gastroparesis Drugs Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Gastroparesis Drugs Sales byType (2020-2025) & (Kg)
Table 47. Europe Gastroparesis Drugs Sales by Application (2020-2025) & (Kg)
Table 48. Middle East & Africa Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
Table 49. Middle East & Africa Gastroparesis Drugs Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Gastroparesis Drugs Sales byType (2020-2025) & (Kg)
Table 51. Middle East & Africa Gastroparesis Drugs Sales by Application (2020-2025) & (Kg)
Table 52. Key Market Drivers & Growth Opportunities of Gastroparesis Drugs
Table 53. Key Market Challenges & Risks of Gastroparesis Drugs
Table 54. Key IndustryTrends of Gastroparesis Drugs
Table 55. Gastroparesis Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Gastroparesis Drugs Distributors List
Table 58. Gastroparesis Drugs Customer List
Table 59. Global Gastroparesis Drugs SalesForecast by Region (2026-2031) & (Kg)
Table 60. Global Gastroparesis Drugs RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Gastroparesis Drugs SalesForecast by Country (2026-2031) & (Kg)
Table 62. Americas Gastroparesis Drugs Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Gastroparesis Drugs SalesForecast by Region (2026-2031) & (Kg)
Table 64. APAC Gastroparesis Drugs Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Gastroparesis Drugs SalesForecast by Country (2026-2031) & (Kg)
Table 66. Europe Gastroparesis Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Gastroparesis Drugs SalesForecast by Country (2026-2031) & (Kg)
Table 68. Middle East & Africa Gastroparesis Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Gastroparesis Drugs SalesForecast byType (2026-2031) & (Kg)
Table 70. Global Gastroparesis Drugs RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Gastroparesis Drugs SalesForecast by Application (2026-2031) & (Kg)
Table 72. Global Gastroparesis Drugs RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Sumitomo Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Sumitomo Gastroparesis Drugs Product Portfolios and Specifications
Table 75. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 76. Sumitomo Main Business
Table 77. Sumitomo Latest Developments
Table 78. Cadila Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
Table 80. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 81. Cadila Pharmaceuticals Main Business
Table 82. Cadila Pharmaceuticals Latest Developments
Table 83. Sanofi Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Gastroparesis Drugs Product Portfolios and Specifications
Table 85. Sanofi Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88.Teva Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89.Teva Gastroparesis Drugs Product Portfolios and Specifications
Table 90.Teva Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 91.Teva Main Business
Table 92.Teva Latest Developments
Table 93. Johnson & Johnson Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Gastroparesis Drugs Product Portfolios and Specifications
Table 95. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Pfizer Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Gastroparesis Drugs Product Portfolios and Specifications
Table 100. Pfizer Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Kyowa Kirin Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
Table 105. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 106. Kyowa Kirin Pharmaceuticals Main Business
Table 107. Kyowa Kirin Pharmaceuticals Latest Developments
Table 108. Hanmi Pharm Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Hanmi Pharm Gastroparesis Drugs Product Portfolios and Specifications
Table 110. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 111. Hanmi Pharm Main Business
Table 112. Hanmi Pharm Latest Developments
Table 113. Ani Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Ani Pharmaceuticals Gastroparesis Drugs Product Portfolios and Specifications
Table 115. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 116. Ani Pharmaceuticals Main Business
Table 117. Ani Pharmaceuticals Latest Developments



LIST OFFIGURES

Figure 1. Picture of Gastroparesis Drugs
Figure 2. Gastroparesis Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gastroparesis Drugs Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Gastroparesis Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Gastroparesis Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Gastroparesis Drugs Sales Market Share by Country/Region (2024)
Figure 10. Gastroparesis Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Prokinetic Agents
Figure 12. Product Picture of Antiemetic Agents
Figure 13. Product Picture of Others
Figure 14. Global Gastroparesis Drugs Sales Market Share byType in 2025
Figure 15. Global Gastroparesis Drugs Revenue Market Share byType (2020-2025)
Figure 16. Gastroparesis Drugs Consumed in Diabetic Gastroparesis
Figure 17. Global Gastroparesis Drugs Market: Diabetic Gastroparesis (2020-2025) & (Kg)
Figure 18. Gastroparesis Drugs Consumed in Idiopathic Gastroparesis
Figure 19. Global Gastroparesis Drugs Market: Idiopathic Gastroparesis (2020-2025) & (Kg)
Figure 20. Global Gastroparesis Drugs Sale Market Share by Application (2024)
Figure 21. Global Gastroparesis Drugs Revenue Market Share by Application in 2025
Figure 22. Gastroparesis Drugs Sales by Company in 2025 (Kg)
Figure 23. Global Gastroparesis Drugs Sales Market Share by Company in 2025
Figure 24. Gastroparesis Drugs Revenue by Company in 2025 ($ millions)
Figure 25. Global Gastroparesis Drugs Revenue Market Share by Company in 2025
Figure 26. Global Gastroparesis Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Gastroparesis Drugs Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Gastroparesis Drugs Sales 2020-2025 (Kg)
Figure 29. Americas Gastroparesis Drugs Revenue 2020-2025 ($ millions)
Figure 30. APAC Gastroparesis Drugs Sales 2020-2025 (Kg)
Figure 31. APAC Gastroparesis Drugs Revenue 2020-2025 ($ millions)
Figure 32. Europe Gastroparesis Drugs Sales 2020-2025 (Kg)
Figure 33. Europe Gastroparesis Drugs Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Gastroparesis Drugs Sales 2020-2025 (Kg)
Figure 35. Middle East & Africa Gastroparesis Drugs Revenue 2020-2025 ($ millions)
Figure 36. Americas Gastroparesis Drugs Sales Market Share by Country in 2025
Figure 37. Americas Gastroparesis Drugs Revenue Market Share by Country (2020-2025)
Figure 38. Americas Gastroparesis Drugs Sales Market Share byType (2020-2025)
Figure 39. Americas Gastroparesis Drugs Sales Market Share by Application (2020-2025)
Figure 40. United States Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Gastroparesis Drugs Sales Market Share by Region in 2025
Figure 45. APAC Gastroparesis Drugs Revenue Market Share by Region (2020-2025)
Figure 46. APAC Gastroparesis Drugs Sales Market Share byType (2020-2025)
Figure 47. APAC Gastroparesis Drugs Sales Market Share by Application (2020-2025)
Figure 48. China Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. India Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. ChinaTaiwan Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Gastroparesis Drugs Sales Market Share by Country in 2025
Figure 56. Europe Gastroparesis Drugs Revenue Market Share by Country (2020-2025)
Figure 57. Europe Gastroparesis Drugs Sales Market Share byType (2020-2025)
Figure 58. Europe Gastroparesis Drugs Sales Market Share by Application (2020-2025)
Figure 59. Germany Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 60.France Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Gastroparesis Drugs Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Gastroparesis Drugs Sales Market Share byType (2020-2025)
Figure 66. Middle East & Africa Gastroparesis Drugs Sales Market Share by Application (2020-2025)
Figure 67. Egypt Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 70.Turkey Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Gastroparesis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Gastroparesis Drugs in 2025
Figure 73. Manufacturing Process Analysis of Gastroparesis Drugs
Figure 74. Industry Chain Structure of Gastroparesis Drugs
Figure 75. Channels of Distribution
Figure 76. Global Gastroparesis Drugs Sales MarketForecast by Region (2026-2031)
Figure 77. Global Gastroparesis Drugs Revenue Market ShareForecast by Region (2026-2031)
Figure 78. Global Gastroparesis Drugs Sales Market ShareForecast byType (2026-2031)
Figure 79. Global Gastroparesis Drugs Revenue Market ShareForecast byType (2026-2031)
Figure 80. Global Gastroparesis Drugs Sales Market ShareForecast by Application (2026-2031)
Figure 81. Global Gastroparesis Drugs Revenue Market ShareForecast by Application (2026-2031)